Schrodinger Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $33.585
- Today's High:
- $34.14
- Open Price:
- $33.77
- 52W Low:
- $15.85
- 52W High:
- $59.24
- Prev. Close:
- $33.99
- Volume:
- 334425
Company Statistics
- Market Cap.:
- $2.64 billion
- Book Value:
- 8.505
- Revenue TTM:
- $193.79 million
- Operating Margin TTM:
- -85.83%
- Gross Profit TTM:
- $101.02 million
- Profit Margin:
- 34.24%
- Return on Assets TTM:
- -13.59%
- Return on Equity TTM:
- 12.02%
Company Profile
Schrodinger Inc had its IPO on 2020-02-06 under the ticker symbol SDGR.
The company operates in the Healthcare sector and Health Information Services industry. Schrodinger Inc has a staff strength of 787 employees.
Stock update
Shares of Schrodinger Inc opened at $33.77 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $33.59 - $34.14, and closed at $33.71.
This is a -0.82% slip from the previous day's closing price.
A total volume of 334,425 shares were traded at the close of the day’s session.
In the last one week, shares of Schrodinger Inc have slipped by -8.17%.
Schrodinger Inc's Key Ratios
Schrodinger Inc has a market cap of $2.64 billion, indicating a price to book ratio of 2.5366 and a price to sales ratio of 8.321.
In the last 12-months Schrodinger Inc’s revenue was $193.79 million with a gross profit of $101.02 million and an EBITDA of $-161160992. The EBITDA ratio measures Schrodinger Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Schrodinger Inc’s operating margin was -85.83% while its return on assets stood at -13.59% with a return of equity of 12.02%.
In Q2, Schrodinger Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 8.5%.
Schrodinger Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 43.7024
- PEG
Its diluted EPS in the last 12-months stands at $0.84 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Schrodinger Inc’s profitability.
Schrodinger Inc stock is trading at a EV to sales ratio of 4.6805 and a EV to EBITDA ratio of -5.8201. Its price to sales ratio in the trailing 12-months stood at 8.321.
Schrodinger Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $841.57 million
- Total Liabilities
- $106.80 million
- Operating Cash Flow
- $67.24 million
- Capital Expenditure
- $2.43 million
- Dividend Payout Ratio
- 0%
Schrodinger Inc ended 2025 with $841.57 million in total assets and $0 in total liabilities. Its intangible assets were valued at $841.57 million while shareholder equity stood at $611.23 million.
Schrodinger Inc ended 2025 with $15.62 million in deferred long-term liabilities, $106.80 million in other current liabilities, 719000.00 in common stock, $-245724000.00 in retained earnings and $4.79 million in goodwill. Its cash balance stood at $285.96 million and cash and short-term investments were $548.67 million. The company’s total short-term debt was $13,921,000 while long-term debt stood at $0.
Schrodinger Inc’s total current assets stands at $591.96 million while long-term investments were $106.40 million and short-term investments were $262.71 million. Its net receivables were $24.24 million compared to accounts payable of $12.43 million and inventory worth $-14585000.00.
In 2025, Schrodinger Inc's operating cash flow was $67.24 million while its capital expenditure stood at $2.43 million.
Comparatively, Schrodinger Inc paid $0 in dividends in 2025.
Other key metrics
- Current Trading Price
- $33.71
- 52-Week High
- $59.24
- 52-Week Low
- $15.85
- Analyst Target Price
- $56.44
Schrodinger Inc stock is currently trading at $33.71 per share. It touched a 52-week high of $59.24 and a 52-week low of $59.24. Analysts tracking the stock have a 12-month average target price of $56.44.
Its 50-day moving average was $42.97 and 200-day moving average was $30.95 The short ratio stood at 5.42 indicating a short percent outstanding of 0%.
Around 633.1% of the company’s stock are held by insiders while 8396.3% are held by institutions.
Frequently Asked Questions About Schrodinger Inc
Similar Industry Stocks (Health Information Services)
Most Active
Top Gainers
Top Losers
About
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.